Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Atropine Sulfate Eye Drops in Healthy Chinese Volunteers
NCT05855018Phase 1Unknown
- Sponsor
- Zhaoke Ophthalmology
- Start
- May 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Myopine in myopia (3 arms), sponsored by Zhaoke Ophthalmology. Primary endpoints: Maximum concentration, Time of Cmax and 8 more. Status: unknown.
02
Drugs
Myopine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05855018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855018.